Searchable abstracts of presentations at key conferences in endocrinology

ea0011p849 | Thyroid | ECE2006

The efficacy of levothyroxine therapy in the nontoxic multinodular goiter

Mihai AM , Ranetti AE , Spiroiu C , Mazilu A , Ranetti C

There is no ideal treatment for the simple goiter. The treatment options in NMG is: surgery, I131, L-thyroxine or continous monitoring without therapy.From 2000–2003 we evaluated 150 patients (120 women and 30 men) having their agings between 20 and 80 years with L-T4 treatment for nontoxic multinodular goiter. Duration of therapy was 3 years. The pacients was evaluated by clinical examination, level of TSH, free-T4,...

ea0073aep54 | Adrenal and Cardiovascular Endocrinology | ECE2021

Adrenal function recovery after successful surgery for Cushing

Marin Alexandra , Mihai Daniel , Caragheorgheopol Andra , Badiu Corin

BackgroundCushing syndrome (CS) is caused by prolonged exposure to elevated cortisol levels and it’s classified as either ACTH-dependent or ACTH independent CS. The most common form of endogenous ACTH CS is Cushing disease (CD); ACTH-independent CS is caused by various adrenal abnormalities. First-line therapy in CS is the resection of the underlying tumor in all cases. After surgical cure of CS, most patients develop transient secondary adrenal ins...

ea0099ep742 | Adrenal and Cardiovascular Endocrinology | ECE2024

Cushing’s syndrome in a patient with non-hodgkin’s lymphoma

Ilie Iuliana , Felicia Mihai Lidia , Lepadat Gabriel , Musat Madalina

Endogenous Cushing’s syndrome is a rare disease, with an incidence of 0.7–2.4 per million people per year. Adrenal origin is described in approximately 20 percent of all cases. Adrenal lymphoma presenting as adrenal incidentaloma with autonomous cortisol production has recently been described, though this is a rare condition. We report a rare case of adrenal Cushing’s syndrome in a patient diagnosed with a low-grade non-Hodgkin’s lymphoma. Female patient, a...

ea0099ep199 | Endocrine-Related Cancer | ECE2024

A rare case of encapsulated medullary thyroid cancer

Mammadov Emin , Bogdan Sandu Ionut , Terzea Dana , Ciprian Stoicea Mihai

Background: Medullary thyroid carcinoma (MTC) is a rare thyroid tumor (around 2% of thyroid cancers). Its prognosis is generally worse than for differentiated thyroid cancers. A very rare subset of MTC is described as encapsulated MTCs. To date, a limited number of case reports and case series have been published, and this type of tumor presents with no evidence of metastases even in case of very high levels of serum calcitonin.Case: A 33-year old pregna...

ea0032p77 | Bone and Osteoporosis | ECE2013

Cathepsin K secretion in human primary osteoblastic cell cultures and its influence by different glucose concentrations

Goia-Socol Monica , Duncea Ileana , Goia-Socol Mihai-Andrei , Hazi Georgeta , Leucuta Daniel-Corneliu , Tomoaie Gheorghe , Suteu Mihai , Georgescu Carmen Emanuela

One of the causes of secondary osteoporosis is type 1 DM (1DM), an autoimmune disease where insulin replacement is mandatory for controlling blood sugar levels. Among the mechanisms involved in osteoporosis in 1DM is increased bone resorption, mainly osteoclasts being responsible for this process. However, osteoblasts also seem to have an active contribution by secreting products with resorptive properties, one of these being cysteine protease Cathepsin K, as mentioned by a fe...

ea0081p539 | Adrenal and Cardiovascular Endocrinology | ECE2022

Hypertension of adrenal origin - a never-ending story

Popa Miruna Maria , Cristina Pascu Raluca , Lucian Pavel Mihai , Malinici Elisabeta Andreea , Sirbu Anca , Simona Fica

Background: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors characterized by a high degree of variability and unpredictability. Coexistence of PPGLs and adrenocortical adenomas is an uncommon occurrence that can further complicate the clinical course. Objective: We describe the diagnostic and management challenges of a patient with a history of surgically removed pheochromocytoma, presenting with symptoms of catecholamine exce...

ea0081p745 | Thyroid | ECE2022

Myxedema coma of both primary and secondary origin, with non-classic presentation and elevated creatine kinase

Lucian Pavel Mihai , Sirbu Anca Elena , Maria Popa Miruna , Bargaoanu Irina , Fica Simona

Introduction: Myxedema coma is the end stage of untreated or inadequately treated hypothyroidism. It has an estimated incidence of 0.22 per million per year. The clinical picture is often that of an elderly obese female, presenting in midwinter with increased lethargy, somnolence and confusion. The presentation is one of severe hypothyroidism, with or without coma.Such cases are predominantly based on a primary thyroid disorder such as Hashimoto′s ...

ea0086p132 | Thyroid | SFEBES2022

Reconsidering the role of thyroidectomy in thyroid eye disease (TED) patients

Sipkova Zuzana , Keren Shay , David Joel , Mihai Radu , Turner Helen , Norris Jonathan

Purpose: Graves’ disease is an autoimmune condition that can cause hyperthyroidism and thyroid eye disease (TED). Definitive treatment is required in approximately 50% patients. Thyroidectomy remains the least chosen primary treatment (2%-18%) despite it having the highest cure rate (>95%). Our aim was to determine the current relationship between patients’ TED and thyroidectomy in a multidisciplinary specialist eye clinic at a tertiary referral centre.<p cla...

ea0065p291 | Neuroendocrinology | SFEBES2019

ACTH producing pancreatic NET

Ashraf Muhammad Masood , May Christine , Anguelova Lia , Tadman Mike , Khan Shahab , Mihai Radu , Jafar-Mohammadi Bahram

We present the case of a 64 year old woman who presented with one month history of tiredness and 8 kg weight loss. Severe hypokalemia (2.2 mmol/l) was identified by the GP. Clinically she appeared mildly Cushingoid. Biochemical investigations showed a random cortisol significantly elevated at 2170 nmol/l, 24-hour urinary cortisol was 15 700 nmol/l(0−135). ACTH level was elevated at 7400 ng/l(0−40). The low dose dexamethasone suppression test demonstrated failure to...

ea0063p461 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Multiple endocrine neoplasia: A case report of a pancreatic neuroendocrine tumor in a long evolving MEN1 patient

Rotarescu Alexandra , Baciu Ionela , Marinescu Mihai , Dumitrascu Anda , Terzea Dana , Poiana Catalina

Introduction: Multiple endocrine neoplasia type 1 (MEN1) is a rare, autosomal dominant inherited syndrome caused by mutations in the MEN1 tumor suppressor gene and is characterized by the occurrence of parathyroid, pancreatic islet and anterior pituitary tumors. We present the case of a female patient known to have pituitary and parathyroid tumors in a MEN1 syndrome evolving for more than 20 years before associating pancreatic neuroendocrine tumor.Case r...